IBDEI1MB ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27071,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,27071,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,27071,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,27072,0)
 ;;=L26.^^132^1309^148
 ;;^UTILITY(U,$J,358.3,27072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27072,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,27072,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,27072,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,27073,0)
 ;;=L27.0^^132^1309^265
 ;;^UTILITY(U,$J,358.3,27073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27073,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,27073,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,27073,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,27074,0)
 ;;=L27.1^^132^1309^266
 ;;^UTILITY(U,$J,358.3,27074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27074,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,27074,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,27074,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,27075,0)
 ;;=L29.0^^132^1309^250
 ;;^UTILITY(U,$J,358.3,27075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27075,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,27075,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,27075,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,27076,0)
 ;;=L29.9^^132^1309^251
 ;;^UTILITY(U,$J,358.3,27076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27076,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,27076,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,27076,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,27077,0)
 ;;=L30.0^^132^1309^232
 ;;^UTILITY(U,$J,358.3,27077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27077,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,27077,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,27077,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,27078,0)
 ;;=L30.1^^132^1309^140
 ;;^UTILITY(U,$J,358.3,27078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27078,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,27078,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,27078,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,27079,0)
 ;;=L30.2^^132^1309^132
 ;;^UTILITY(U,$J,358.3,27079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27079,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,27079,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,27079,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,27080,0)
 ;;=L30.4^^132^1309^144
 ;;^UTILITY(U,$J,358.3,27080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27080,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,27080,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,27080,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,27081,0)
 ;;=L30.8^^132^1309^135
 ;;^UTILITY(U,$J,358.3,27081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27081,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,27081,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,27081,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,27082,0)
 ;;=L30.9^^132^1309^136
 ;;^UTILITY(U,$J,358.3,27082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27082,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,27082,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,27082,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,27083,0)
 ;;=L40.0^^132^1309^253
 ;;^UTILITY(U,$J,358.3,27083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27083,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,27083,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,27083,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,27084,0)
 ;;=L40.1^^132^1309^256
 ;;^UTILITY(U,$J,358.3,27084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27084,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,27084,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,27084,2)
 ;;=^5009161
